Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
30.24
+0.59 (1.99%)
At close: Mar 6, 2026, 4:00 PM EST
30.40
+0.16 (0.53%)
After-hours: Mar 6, 2026, 4:35 PM EST
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.44 billion as of March 6, 2026. Its market cap has increased by 203.11% in one year.
Market Cap
1.44B
Enterprise Value
940.12M
1-Year Change
203.11%
Ranking
Category
Stock Price
$30.24
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.44B, an increase of 139.65%. That is a compound annual growth rate of 65.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.44B | -0.33% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 1.55B |
| Kodiak Sciences | 1.54B |
| Vir Biotechnology | 1.53B |
| Ardelyx | 1.52B |
| Biohaven | 1.49B |
| Capricor Therapeutics | 1.44B |
| MBX Biosciences | 1.44B |
| Generate Biomedicines | 1.43B |